We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+12.93%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$287M
AUM Growth
-$6.85M
Cap. Flow
-$32.6M
Cap. Flow %
-11.38%
Top 10 Hldgs %
72.59%
Holding
37
New
Increased
3
Reduced
15
Closed

Top Buys

Rank Stock Value
1
DAR icon
Darling Ingredients
DAR
+$3.18M
2
VICR icon
Vicor
VICR
+$441K
3
PSNL icon
Personalis
PSNL
+$194K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7.59M
2
ALL icon
Allstate
ALL
+$3.91M
3
ABBV icon
AbbVie
ABBV
+$3.64M
4
XEL icon
Xcel Energy
XEL
+$3M
5
T icon
AT&T
T
+$2.37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.78%
2 Utilities 28.46%
3 Industrials 19.55%
4 Communication Services 6.73%
5 Financials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBU icon
26
Caribou Biosciences
CRBU
$164M
$1.15M 0.4%
200,000
MASS icon
27
908 Devices
MASS
$302M
$766K 0.27%
68,286
MNKD icon
28
MannKind Corp
MNKD
$1.25B
$710K 0.25%
195,073
VTRS icon
29
Viatris
VTRS
$20.1B
$631K 0.22%
58,252
PSNL icon
30
Personalis
PSNL
$1.61B
$630K 0.22%
300,000
+150,000
+100% +$194K
IGMS
31
DELISTED
IGM Biosciences
IGMS
$540K 0.19%
65,000
-55,000
-46% -$319K
FATE icon
32
Fate Therapeutics
FATE
$324M
$535K 0.19%
143,000
-57,000
-29% -$135K
OGN icon
33
Organon & Co
OGN
$3.55B
$450K 0.16%
31,190
RLI icon
34
RLI Corp
RLI
$5.66B
$266K 0.09%
4,000
WBD icon
35
Warner Bros
WBD
$67.4B
$121K 0.04%
10,642
-1,209
-10% -$13.1K

Similar funds

Bruce & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Bruce & Co held 37 positions worth $287M, down 2.3% from $293M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bruce & Co withdrew a net $32.6M in Q4 2023, reducing 15 holdings. Its largest reduction was Pfizer, cutting an estimated $7.59M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 34% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co added an estimated $3.18M to Darling Ingredients.

  • Bruce & Co added most to Darling Ingredients in Q4 2023, an estimated $3.18M increase.
  • Bruce & Co's biggest Q4 2023 reduction was Pfizer, cutting an estimated $7.59M.
  • Bruce & Co's ten largest holdings make up 73% of its $287M portfolio in Q4 2023.
  • Bruce & Co opened 0 new positions and closed 0 in Q4 2023.
  • Bruce & Co's portfolio value fell 2.3% quarter-over-quarter to $287M.

Based on Bruce & Co's 13F filing for Q4 2023, filed 12 Feb 2024.